The CIOCD Specialty OCD Training and Accreditation Program
Treatment for Obsessive Compulsive Disorder is a specialized field. The national and global cost of the suffering and disability of the many OCD children, adolescents, and adults without access to timely specialty treatments is devastating. An increase in the number of clinicians specialized to treat and to supervise the treatment of OCD is urgently needed.
To address the urgent need for dissemination of expertise the CIOCD has established the Specialty Training and Accreditation Program for OCD through the lifespan. This program is designed to increase evidence based specialty expertise in assessment and treatment for OCD across Canada as well as internationally.
The CIOCD International Accreditation Task Force (ATF) comprises experts on specialty treatments for OCD and related disorders through the lifespan, representing 14 nations. This task force has established phase 2 specialty knowledge and competency standards recommended for evidence based specialized clinical practice for OCD through the lifespan (specialty CBT, and pharmacotherapy). The ATF aim is to achieve transformative international improvement in accessibility to specialized treatments and to address the serious insufficiency of experts in this field. ATF phase 1 was completed with publication of a special review series, Psychiatry Research, 2015.
Available clinical research and the experience of OCD experts indicate that timely evidence based specialty treatment is required to optimize symptom remission for OCD sufferers. Training in general psychiatry, psychology, and/or cognitive behavior therapy (CBT) are not necessarily sufficient to acquire the specialized clinical skills required for best practice treatment of varied OCD symptom subtypes and related difficulties.
Current widely used training models, such as educational and training workshops, are helpful to communicate diagnostic issues and basic treatment interventions but cannot cover the complex skills required to address OCD subtypes and related difficulties to the recommended level of specialized practice. Further, there are insufficient academic training programs that offer treatment of OCD as a training elective to our next generation.
During ATF phase 3 certification (individuals) and accreditation (sites) criteria and dissemination processes will be developed and implemented based on the established evidence based standards, with specific educational and clinical qualifications required for candidacy. The ATF comprises the expertise and representation required for broad international implementation.
An advanced training program will be offered to mental health professionals and centers based on the established standards. Specialty certification or accreditation will be awarded to qualified mental health professionals or treatment sites (respectively) that fulfill advanced-level specialty training and practice criteria. Several modalities of teaching, training, supervision, and consultation will be required, for example, in collaboration with University Directors of Training to increase specialized training programs that offer an elective rotation in this field.
Individuals and centers awarded CIOCD specialty certification or accreditation for clinical work or supervisory status with children, adolescents, or adults suffering from OCD will be listed on the Institute website and their contact information will be made accessible to OCD sufferers.
This process is currently ongoing for OCD and will then be undertaken for OCD-Related Disorders.
Please see five paper Special Issue: Knowledge and Competency Standards for Specialized Treatments for OCD Through the Lifespan, Psychiatry Research, 2021.
Sookman, D., Phillips, K.A., Mataix-Cols, D., Veale, D., 2021. Introduction to knowledge and competency standards for specialized treatments for obsessive-compulsive disorder throughout the lifespan: phase two series by the International Accreditation Task Force of The Canadian Institute for Obsessive Compulsive Disorders (CIOCD, www.ciocd.ca). Psychiatry Res. 298. 113753. https://doi.org/10.1016/j.psychres.2021.113753..